CompuMed (OTCMKTS:CMPD) Releases Earnings Results

CompuMed (OTCMKTS:CMPDGet Free Report) released its earnings results on Monday. The company reported ($0.06) earnings per share (EPS) for the quarter, Zacks reports. The company had revenue of $2.03 million during the quarter. CompuMed had a negative net margin of 2.51% and a negative return on equity of 6.25%.

CompuMed Trading Down 3.6%

OTCMKTS:CMPD opened at $6.51 on Wednesday. The firm has a market cap of $8.66 million, a P/E ratio of -43.40 and a beta of -0.53. The company has a current ratio of 2.04, a quick ratio of 2.01 and a debt-to-equity ratio of 0.16. The stock’s 50 day simple moving average is $6.33 and its 200-day simple moving average is $4.67. CompuMed has a 12-month low of $1.95 and a 12-month high of $6.95.

About CompuMed

(Get Free Report)

CompuMed, Inc, an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults.

Featured Stories

Earnings History for CompuMed (OTCMKTS:CMPD)

Receive News & Ratings for CompuMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CompuMed and related companies with MarketBeat.com's FREE daily email newsletter.